Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
DNA Damage Response
100%
Homologous Recombination
73%
Cancer Cell
39%
RNA Processing
32%
DNA Repair
29%
Recombination Repair
29%
Transcription Elongation
28%
DNA Damage
26%
Phosphotransferase
24%
Kinase
24%
Gene Expression Profiling
24%
Gene Dosage
24%
Ataxia Telangiectasia and Rad3 Related
24%
Wee1
24%
Transcription Regulation
24%
Polyadenylation
24%
METTL3
24%
Cyclin-Dependent Kinase
24%
Metastasis Inhibition
24%
Small Molecule
24%
Tumor Progression
24%
Methyltransferase
24%
Gene Expression
19%
Interphase
17%
Genome Instability
12%
Cell Cycle
9%
Cell Cycle Checkpoint
9%
Cell Cycle Arrest
9%
P53
9%
Gene Expression Level
8%
Messenger RNA
8%
Functional Genomics
8%
Biological Functions
8%
Immunology and Microbiology
DNA Damage Response
87%
Homologous Recombination
48%
Cycline
48%
Cancer Cell
36%
Cell Cycle
34%
DNA Repair
29%
Cytotoxicity
29%
DNA Damage
26%
Cell Lineage
24%
Lineage
24%
Recombination Repair
24%
Cell Line
24%
Osteosarcoma Cell
24%
Neuroblastoma Cell
24%
Polyadenylation
24%
Gene Expression Assay
21%
RNA Processing
20%
Interphase
17%
RNA Polymerase
16%
Transcription Elongation
16%
Carboxy Terminal Sequence
16%
Cell Death
12%
Metastasis Inhibition
12%
Transcription Regulation
12%
Upregulation
12%
Genetic Transcription
12%
Mouse Model
12%
Downregulation
12%
Enhancer Region
12%
Cell Cycle Progression
12%
Xenograft
12%
Cell Viability
12%
Cell Cycle Checkpoint
9%
Cell Cycle Arrest
9%
P53
9%
Medicine and Dentistry
DNA Damage Response
31%
Recombination Repair
24%
Cancer Therapy
24%
Homologous Recombination
24%
Neoplasm
24%
METTL3
24%
Osteosarcoma
24%
Ex Vivo
24%
Ganglioneuroblastoma
24%
Lung
19%
DNA Damage
17%
Cell Cycle
17%
Cyclin-Dependent Kinase
12%
Neuroblastoma Cell
12%
Cytotoxicity
12%
Cell Line
12%
DNA Repair
9%
Osteosarcoma Cell
9%
Cyclin-Dependent Kinase 7
6%
Target Validation
6%
Malignant Neoplasm
6%
RNA Polymerase II
6%
Downregulation
6%
Carboxy Terminal Sequence
6%
Gene Expression Profiling
6%
Cell Cycle Progression
6%
Cell Viability
6%
Tumor Regression
6%
Genetic Transcription
6%
Combination Therapy
6%
Xenograft
6%
Polymerase
6%
Cell Death
6%
Enhancer Region
6%
Kinase
6%
Upregulation
6%